Sick Money | Hardcover

Sick Money: The Truth About the Global Pharmaceutical Industry

Format: Hardcover
Pages: 423
Date of Release: 3 May 2022

In Sick Money, investigative journalist Billy Kenber delivers a powerful and deeply researched examination of the modern pharmaceutical industry and the growing tension between public health and corporate profit. This compelling exposé reveals how a system originally designed to develop life-saving medicines and improve patient care has increasingly become driven by financial interests, shareholder demands, and aggressive market strategies.

Drawing on real-world investigations from across the globe, Kenber uncovers shocking stories of price manipulation, drug shortages, corporate misconduct, and the commercialization of essential medicines. From dramatic overnight price hikes on critical drugs to life-saving treatments becoming inaccessible to ordinary patients, the book explores how medicines are often treated as financial assets rather than public necessities.

The book examines the influence of hedge funds, pharmaceutical giants, private investors, and secretive pricing deals that shape who receives treatment and who is left behind. It also investigates issues including bribery scandals, patent battles, healthcare inequality, and the growing pressures placed on national health systems around the world.

Despite its alarming revelations, Sick Money is not simply a critique—it also offers thoughtful analysis on how the pharmaceutical system might be reformed to prioritize innovation, affordability, transparency, and patient wellbeing. Written in an accessible and engaging style, the book combines investigative reporting with economic, political, and ethical insights to explain one of the most important global issues of our time.

Essential reading for anyone interested in healthcare, medicine, economics, ethics, public policy, or investigative journalism, Sick Money provides a revealing look into the hidden forces shaping the future of modern healthcare.

Sick Money, Billy Kenber, pharmaceutical industry books, healthcare corruption, investigative journalism books, global healthcare system, medicine pricing, pharmaceutical ethics, public health books, healthcare economics, drug industry exposé, medical industry corruption, healthcare policy books, pharmaceutical profits, access to medicine, health inequality, current affairs books, nonfiction healthcare books, medical business, healthcare reform